Jazz Pharmaceuticals - 48 Year Dividend History | JAZZ

Historical dividend payout and yield for Jazz Pharmaceuticals (JAZZ) since 1971. The current TTM dividend payout for Jazz Pharmaceuticals (JAZZ) as of June 25, 2019 is $0.00. The current dividend yield for Jazz Pharmaceuticals as of June 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.731B $1.891B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.500B 34.82
Takeda Pharmaceutical (TAK) Japan $27.482B 8.07
Grifols (GRFS) Spain $13.834B 17.50
Mannatechorporated (MTEX) United States $0.040B 0.00